EA201490712A1 - SYNERGETIC HERBAL COMPOSITION FOR PREVENTION AND TREATMENT OF DIABETIC RETINOPATHY AND CATARACT - Google Patents
SYNERGETIC HERBAL COMPOSITION FOR PREVENTION AND TREATMENT OF DIABETIC RETINOPATHY AND CATARACTInfo
- Publication number
- EA201490712A1 EA201490712A1 EA201490712A EA201490712A EA201490712A1 EA 201490712 A1 EA201490712 A1 EA 201490712A1 EA 201490712 A EA201490712 A EA 201490712A EA 201490712 A EA201490712 A EA 201490712A EA 201490712 A1 EA201490712 A1 EA 201490712A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- cataract
- treatment
- diabetic retinopathy
- prevention
- synergetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Настоящее изобретение относится к синергической травяной композиции для профилактики и лечения вторичных осложнений, связанных с сахарным диабетом, таких как диабетическая ретинопатия и катаракта, и способу её получения в фармацевтически приемлемых лекарственных формах и её применению в лечении диабетической ретинопатии и катаракты.The present invention relates to a synergistic herbal composition for the prevention and treatment of secondary complications associated with diabetes mellitus, such as diabetic retinopathy and cataract, and to a method for its preparation in pharmaceutically acceptable dosage forms and its use in the treatment of diabetic retinopathy and cataract.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3134DE2011 | 2011-11-03 | ||
| PCT/IB2012/056105 WO2013065015A2 (en) | 2011-11-03 | 2012-11-02 | A synergistic herbal composition for prevention and treatment of diabetic retinopathy and cataract |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201490712A1 true EA201490712A1 (en) | 2014-12-30 |
| EA028459B1 EA028459B1 (en) | 2017-11-30 |
Family
ID=47356241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201490712A EA028459B1 (en) | 2011-11-03 | 2012-11-02 | Synergistic herbal composition for prevention and treatment of diabetic retinopathy and cataract |
Country Status (3)
| Country | Link |
|---|---|
| EA (1) | EA028459B1 (en) |
| UA (1) | UA116977C2 (en) |
| WO (1) | WO2013065015A2 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7014872B2 (en) * | 2002-03-26 | 2006-03-21 | Council Of Scientific And Industrial Research | Herbal nutraceutical formulation for diabetics and process for preparing the same |
| WO2005076750A2 (en) | 2004-02-18 | 2005-08-25 | Lanson Biotech | A novel synergistic herbal formulation for diabetes cure |
| US20060099279A1 (en) | 2004-11-09 | 2006-05-11 | Council Of Scientific & Industrial Research | Novel anti-diabetic herbal formulation |
| CN101287481A (en) | 2005-05-26 | 2008-10-15 | 科学工业研究委员会 | A pharmaceutical composition useful for the treatment of hepatocellular carcinoma |
-
2012
- 2012-02-11 UA UAA201406098A patent/UA116977C2/en unknown
- 2012-11-02 WO PCT/IB2012/056105 patent/WO2013065015A2/en active Application Filing
- 2012-11-02 EA EA201490712A patent/EA028459B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EA028459B1 (en) | 2017-11-30 |
| WO2013065015A2 (en) | 2013-05-10 |
| UA116977C2 (en) | 2018-06-11 |
| WO2013065015A3 (en) | 2013-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013009948A (en) | Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders. | |
| EA201491060A1 (en) | NEW DERIVATIVES OF TRIFTOROMETHYLOROXIAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE | |
| CL2013003372A1 (en) | Compounds derived from spiro- [1,3] -oxacins and spiro- [1,4] -oxacepins, inhibitors of bace1 and / or bace2; pharmaceutical composition; procedure to prepare them; and its use in the treatment and / or prophylaxis of Alzheimer's disease and diabetes. | |
| EA201490228A1 (en) | NEW DERIVATIVES OF TRIFTOROMETHYLOROXIAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE | |
| MY171920A (en) | Prevention and treatment of ocular conditions | |
| PL3517539T3 (en) | Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes | |
| MX2015008114A (en) | Exendin-4 Derivatives. | |
| ECSP12012310A (en) | 5-FLUORO-1H-REPLACED PIRAZOLOPIRIDINES AND ITS USE | |
| WO2013158928A3 (en) | Chemosensory receptor ligand-based therapies | |
| GB201118656D0 (en) | New compounds | |
| WO2013186240A3 (en) | Exendin-4 peptide analogues | |
| EA201490378A1 (en) | TREATMENT OF MULTIPLE SCLEROSIS USING THE COMBINATION OF LACHINIMODA AND INTERFERON-β | |
| BR112014031091A2 (en) | PIPERIDINE DERIVATIVES FOR GPR119 AGONIST | |
| IL219534A0 (en) | Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema | |
| BR112013030554A2 (en) | crystalline form of cyclosporin a, methods of preparation and methods for its use | |
| ES2429422R1 (en) | Pharmaceutical composition and its use to prepare a medicine for the treatment and prevention of HIV diseases | |
| EP2796450A4 (en) | 6-aminopyridine-3-ol derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical composition containing same as active ingredients for preventing or treating diseases caused by angiogenesis | |
| DOP2013000314A (en) | TYPICAL OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB | |
| EA201491532A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR USE IN COMPLEX THERAPY | |
| AR091724A1 (en) | TREATMENT OF MULTIPLE SCLEROSIS WITH A COMBINATION OF LAQUINIMOD AND FAMPRIDINE, PHARMACEUTICAL COMPOSITION | |
| EA201301308A1 (en) | COMBINATION FOR THE TREATMENT OF DIABETES MELLITUS | |
| MX2013010415A (en) | Treatment of vaginal atrophy as novel indication for myrrh. | |
| EA201490712A1 (en) | SYNERGETIC HERBAL COMPOSITION FOR PREVENTION AND TREATMENT OF DIABETIC RETINOPATHY AND CATARACT | |
| EA201500694A1 (en) | MONOLITHIC MEDICAL FORM FOR MODIFIED SURVIVAL OF A COMBINATION OF ACTIVE INGREDIENTS | |
| ECSP15025868A (en) | COMPOSITION INCLUDING AN ISOLATED PURIFIED EXTRACT OF PSEUDOLYSIMACHION ROTUNDUM VAR. SUBINTEGRUM CONTAINING AN ABUNDANT QUANTITY OF ACTIVE INGREDIENT OR THE ISOLATED COMPOUNDS THEREOF, AS AN ACTIVE INGREDIENT TO PREVENT / TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND ITS USE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ TJ TM |